Researchers have identified the gene STMN2 as a novel biomarker and potential drug target for ALS.
A new study reveals many inhibitory neurons are lost in early phases of ALS and FTD development. The findings show a contrast to other neurodegenerative diseases where excitatory neurons are lost early in the disorders.
A new study sheds light on the molecular mechanisms behind ALS.
Researchers report microglia is critical for neuronal survival in ALS.
A new mouse model has been developed that captures the pathology of sporadic neurodegenerative diseases.
Researchers have identified a genetic mutation associated with both ALS and frontotemporal dementia.
A new study sheds light on how some forms of motor neuron disease begins and progresses at a cellular level.
New studies find a drug designed to combat the gene that causes SCA2 could also be beneficial in the fight against ALS.
Researchers have developed a new mouse model of ALS that could help provide better understanding of the progressive nature of the disease.
A new study reports on the role the protein TDP-43 plays in the development of Alzheimer's disease.
Researchers have identified one way in which an RNA binding protein may contribute to ALS.
Research using C. elegans finds maple syrup may protect neurons and prevent the development of ALS.
